Works matching DE "ROSIGLITAZONE"

Results: 699

The Risk of Fractures Associated with Thiazolidinediones: A Self-controlled Case-Series Study.

Published in:

PLoS Medicine, 2009, v. 6, n. 9, p. 1, doi. 10.1371/journal.pmed.1000154

By:

Douglas, Ian J.;
Evans, Stephen J.;
Pocock, Stuart;
Smeeth, Liam

Publication type:

Article

Phase I clinical trial of oral rosiglitazone in combination with intravenous carboplatin in cancer-bearing dogs.

Published in:

Veterinary & Comparative Oncology, 2014, v. 12, n. 1, p. 1, doi. 10.1111/j.1476-5829.2012.00322.x

By:

Allstadt Frazier, S.;
McKemie, D. S.;
Guerrero, T. A.;
LaChapelle, H.;
Skorupski, K. A.;
Kass, P. H.;
Rodriguez, C. O.

Publication type:

Article

Thiazolidinediones improve flow-mediated dilation: a meta-analysis of randomized clinical trials.

Published in:

European Journal of Clinical Pharmacology, 2016, v. 72, n. 4, p. 385, doi. 10.1007/s00228-015-1999-4

By:

Stojanović, Marko;
Prostran, Milica;
Radenković, Miroslav

Publication type:

Article

Application of in vitro-in vivo extrapolation (IVIVE) and physiologically based pharmacokinetic (PBPK) modelling to investigate the impact of the CYP2C8 polymorphism on rosiglitazone exposure.

Published in:

European Journal of Clinical Pharmacology, 2013, v. 69, n. 6, p. 1311, doi. 10.1007/s00228-012-1467-3

By:

Yeo, Karen;
Kenny, Jane;
Rostami-Hodjegan, Amin

Publication type:

Article

Pharmacokinetic drug interaction between gemfibrozil and sitagliptin in healthy Indian male volunteers.

Published in:

European Journal of Clinical Pharmacology, 2012, v. 68, n. 5, p. 709, doi. 10.1007/s00228-011-1177-2

By:

K. P., Arun;
Meda, Venkata;
Kucherlapati, V.;
Dubala, Anil;
M., Deepalakshmi;
P. R., Anand;
K., Elango;
B., Suresh

Publication type:

Article

Peroxisome proliferator-activated receptor-γ activation attenuates cardiac fibrosis in type 2 diabetic rats: the effect of rosiglitazone on myocardial expression of receptor for advanced glycation end products and of connective tissue growth factor

Published in:

Basic Research in Cardiology, 2010, v. 105, n. 3, p. 399, doi. 10.1007/s00395-009-0071-x

By:

Sang-Hyun Ihm;
Kiyuk Chang;
Hee-Yeol Kim;
Sang Hong Baek;
Ho-Joong Youn;
Ki-Bae Seung;
Jae-Hyung Kim

Publication type:

Article

Growth Hormone Mediators and Glycemic Control in Youths With Type 2 Diabetes: A Secondary Analysis of a Randomized Clinical Trial.

Published in:

JAMA Network Open, 2024, v. 7, n. 2, p. e240447, doi. 10.1001/jamanetworkopen.2024.0447

By:

Lu, Chang;
Wolfs, Danielle;
El ghormli, Laure;
Levitsky, Lynne L.;
Levitt Katz, Lorraine E.;
Laffel, Lori M.;
Patti, Mary-Elizabeth;
Isganaitis, Elvira

Publication type:

Article

Effect of Rosiglitazone on Liver Structure and Function in Genetically Diabetic Akita Mice.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2013, v. 113, n. 5, p. 353, doi. 10.1111/bcpt.12104

By:

Hemmeryckx, Bianca;
Gaekens, Marijke;
Gallacher, David J.;
Lu, Hua Rong;
Lijnen, Henri Roger

Publication type:

Article

The Influence of Oral Antidiabetic Drugs on Cellular Drug Uptake Mediated by Hepatic OATP Family Members.

Published in:

Basic & Clinical Pharmacology & Toxicology, 2013, v. 112, n. 4, p. 244, doi. 10.1111/bcpt.12031

By:

Klatt, Sabine;
Fromm, Martin F.;
König, Jörg

Publication type:

Article

Rosiglitazone influences adipose tissue distribution without deleterious impact on heart rate variability in coronary heart disease patients with type 2 diabetes.

Published in:

Clinical Autonomic Research, 2016, v. 26, n. 6, p. 407, doi. 10.1007/s10286-016-0373-7

By:

Grenier, Audrey;
Brassard, Patrice;
Bertrand, Olivier;
Després, Jean-Pierre;
Costerousse, Olivier;
Alméras, Natalie;
Poirier, et

Publication type:

Article

Effects of rosiglitazone, an antidiabetic drug, on Kv3.1 channels.

Published in:

Korean Journal of Physiology & Pharmacology, 2023, v. 27, n. 1, p. 95, doi. 10.4196/kjpp.2023.27.1.95

By:

Hyang Mi Lee;
Seong Han Yoon;
Min-Gul Kim;
Sang June Hahn;
Bok Hee Choi

Publication type:

Article

The antidiabetic drug rosiglitazone blocks Kv1.5 potassium channels in an open state.

Published in:

Korean Journal of Physiology & Pharmacology, 2022, v. 26, n. 2, p. 135, doi. 10.4196/kjpp.2022.26.2.135

By:

Hyang Mi Lee;
Sang June Hahn;
Bok Hee Choi

Publication type:

Article

Managing Comorbidities in Patients with Chronic Heart Failure: First, Do No Harm.

Published in:

American Journal of Cardiovascular Drugs, 2015, v. 15, n. 3, p. 171, doi. 10.1007/s40256-015-0115-6

By:

DeJongh, Beth;
Birkeland, Kade;
Brenner, Michael

Publication type:

Article

Pioglitazone is a Valid Alternative to Rosiglitazone.

Published in:

American Journal of Cardiovascular Drugs, 2011, v. 11, n. 6, p. 357, doi. 10.2165/11595990-000000000-00000

By:

Derosa, Giuseppe

Publication type:

Article

Thiazolidinediones and Risk of Heart Failure in Patients with or at High Risk of Type 2 Diabetes Mellitus: A Meta-Analysis and Meta-Regression Analysis of Placebo-Controlled Randomized Clinical Trials.

Published in:

American Journal of Cardiovascular Drugs, 2011, v. 11, n. 2, p. 115, doi. 10.2165/11587580-000000000-00000

By:

Hernandez, Adrian V.;
Usmani, Ali;
Rajamanickam, Anitha;
Moheet, A.

Publication type:

Article

Expression of Concern on “The Novel Oral Drug Subetta Exerts an Antidiabetic Effect in the Diabetic Goto-Kakizaki Rat: Comparison with Rosiglitazone”.

Published in:: Journal of Diabetes Research, 2019, p. 1, doi. 10.1155/2019/2938413
Publication type:: Article

Mechanisms responsible for beneficial and adverse effects of rosiglitazone in a rat model of acute cardiac ischaemia-reperfusion.

Published in:

Experimental Physiology, 2013, v. 98, n. 5, p. 1028, doi. 10.1113/expphysiol.2012.070433

By:

Palee, Siripong;
Weerateerangkul, Punate;
Chinda, Kroekkiat;
Chattipakorn, Siriporn C.;
Chattipakorn, Nipon

Publication type:

Article

Effect of rosiglitazone on cardiac electrophysiology, infarct size and mitochondrial function in ischaemia and reperfusion of swine and rat heart.

Published in:

Experimental Physiology, 2011, v. 96, n. 8, p. 778, doi. 10.1113/expphysiol.2011.057885

By:

Palee, Siripong;
Weerateerangkul, Punate;
Surinkeaw, Sirirat;
Chattipakorn, Siriporn;
Chattipakorn, Nipon

Publication type:

Article

Antitumor action of the peroxisome proliferator-activated receptor-γ agonist rosiglitazone in hepatocellular carcinoma.

Published in:

Oncology Letters, 2015, v. 10, n. 4, p. 1979, doi. 10.3892/ol.2015.3554

By:

QI-FU BO;
XIU-MEI SUN;
JIN LIU;
XIAO-MEI SUI;
GUI-XIN LI

Publication type:

Article

Rosiglitazone amplifies the sensitivity of docetaxel and reduces the expression of CD44v6.

Published in:

Oncology Letters, 2014, v. 7, n. 4, p. 1284, doi. 10.3892/ol.2014.1824

By:

FAHE JI;
DONGCHU MA;
ZHAOZHE LIU;
XIAODONG XIE

Publication type:

Article

Rosiglitazone Protects Endothelial Cells From Irradiation-Induced Mitochondrial Dysfunction.

Published in:

Frontiers in Pharmacology, 2020, p. 1, doi. 10.3389/fphar.2020.00268

By:

Baselet, Bjorn;
Driesen, Ronald B.;
Coninx, Emma;
Belmans, Niels;
Sieprath, Tom;
Lambrichts, Ivo;
De Vos, Winnok H.;
Baatout, Sarah;
Sonveaux, Pierre;
Aerts, An

Publication type:

Article

Can Metformin or Rosiglitazone Reduce Metabolic Side Effects Associated with Atypical Antipsychotics?

Published in:

Issues in Mental Health Nursing, 2009, v. 30, n. 12, p. 803, doi. 10.3109/01612840903276712

By:

Housel, Audrey K.;
Waterbury, Nancee;
Argo, Tami R.;
Roman, Marian

Publication type:

Article

New Insight into the Treatment of Advanced Differentiated Thyroid Cancer.

Published in:

Journal of Thyroid Research, 2012, p. 1, doi. 10.1155/2012/437569

By:

Safavi, Arash;
Vijayasekaran, Aparna;
Guerrero, Marlon A.

Publication type:

Article

Effects of nateglinide and rosiglitazone on pancreatic alpha- and beta-cells, GLP-1 secretion and inflammatory markers in patients with type 2 diabetes: randomized crossover clinical study.

Published in:

Diabetology & Metabolic Syndrome, 2016, v. 4, p. 1, doi. 10.1186/s13098-015-0120-6

By:

Ulhôa Tostes, Glauce Cordeiro;
Rosário Cunha, Maria;
Rosa Tsumeshiro Fukui;
Silva Correia, Márcia Regina;
Rocha, Dalva Marreiro;
dos Santos, Rosa Ferreira;
da Silva, Maria Elizabeth Rossi

Publication type:

Article

Management of cardiac fibrosis in diabetic rats; the role of peroxisome proliferator activated receptor gamma (PPAR-gamma) and calcium channel blockers (CCBs).

Published in:

Diabetology & Metabolic Syndrome, 2011, v. 3, n. 1, p. 1, doi. 10.1186/1758-5996-3-4

By:

Mohamad, Hoda E.;
Askar, Mervat E.;
Hafez, Mohamed M.

Publication type:

Article

Impact of Sex on the Therapeutic Efficacy of Rosiglitazone in Modulating White Adipose Tissue Function and Insulin Sensitivity.

Published in:

Nutrients, 2024, v. 16, n. 18, p. 3063, doi. 10.3390/nu16183063

By:

Bauzá-Thorbrügge, Marco;
Amengual-Cladera, Emilia;
Galmés-Pascual, Bel Maria;
Morán-Costoya, Andrea;
Gianotti, Magdalena;
Valle, Adamo;
Proenza, Ana Maria;
Lladó, Isabel

Publication type:

Article

Effects of rosiglitazone pretreatment on blood glucose, lipid levels, urea, and microalbuminuria in rats undergoing 70% pancreatectomy.

Published in:

Open Access Surgery, 2013, v. 6, p. 1, doi. 10.2147/OAS.S39364

By:

Zafe Acar, Hasan;
Okan Senel, Oytun;
Bukan, Neslihan;
Yurekli, Banu;
Ebru Salman, A.;
Yetisir, Fahri

Publication type:

Article

Postnatal Rosiglitazone Administration to Neonatal Rat Pups Does Not Alter the Young Adult Metabolic Phenotype.

Published in:

Neonatology (16617800), 2012, v. 101, n. 3, p. 217, doi. 10.1159/000331772

By:

Truong, Nghia C.;
Abbasi, Afshan;
Sakurai, Reiko;
Lee, W.N. Paul;
Torday, John S.;
Rehan, Virender K.

Publication type:

Article

Bioanalytical Method for Carbocisteine in Human Plasma by Using LC-MS/MS: A Pharmacokinetic Application.

Published in:

Scientia Pharmaceutica, 2014, v. 82, n. 4, p. 765, doi. 10.3797/scipharm.1403-12

By:

DHANURE, Shivanand;
SAVALIA, Atulkumar;
MORE,, Pravinkumar;
SHIRODE, Prashant;
KAPSE, Kailas;
MORE, Virag

Publication type:

Article

Bioanalytical Method for Carbocisteine in Human Plasma by Using LC-MS/MS: A Pharmacokinetic Application.

Published in:

Scientia Pharmaceutica, 2014, v. 82, n. 4, p. 765, doi. 10.3797/scipharm.1403-12

By:

DHANURE, Shivanand;
SAVALIA, Atulkumar;
MORE, Pravinkumar;
SHIRODE, Prashant;
KAPSE, Kailas;
SHAH, Virag

Publication type:

Article

Effect of rosiglitazone on the risk for myocardial infarction and death from cardiovascular causes.

Published in:: Einstein (16794508), 2009, v. 7, n. 1, p. 24
Publication type:: Article

Prenatal treatment with rosiglitazone attenuates vascular remodeling and pulmonary monocyte influx in experimental congenital diaphragmatic hernia.

Published in:

PLoS ONE, 2018, v. 13, n. 11, p. 1, doi. 10.1371/journal.pone.0206975

By:

Gosemann, Jan-Hendrik;
Friedmacher, Florian;
Hofmann, Alejandro;
Zimmer, Julia;
Kuebler, Joachim F.;
Rittinghausen, Susanne;
Suttkus, Anne;
Lacher, Martin;
Alvarez, Luis;
Corcionivoschi, Nicolae;
Puri, Prem

Publication type:

Article

A systems biology approach to understand the pathophysiological mechanisms of cardiac pathological hypertrophy associated with rosiglitazone.

Published in:

BMC Medical Genomics, 2014, v. 7, n. 1, p. 2, doi. 10.1186/1755-8794-7-35

By:

Verschuren, Lars;
Wielinga, Peter Y.;
Kelder, Thomas;
Radonjic, Marijana;
Salic, Kanita;
Kleemann, Robert;
van Ommen, Ben;
Kooistra, Teake

Publication type:

Article

PPARγ agonist rosiglitazone inhibits migration and invasion by downregulating Cyr61 in rheumatoid arthritis fibroblast-like synoviocytes.

Published in:

International Journal of Rheumatic Diseases, 2017, v. 20, n. 10, p. 1499, doi. 10.1111/1756-185X.12913

By:

Kwon, Eun ‐ Jeong;
Park, Eun ‐ Jung;
Choi, Sungwook;
Kim, Sang ‐ Rim;
Cho, Moonjae;
Kim, Jinseok

Publication type:

Article

1.1 Genomics, genetic basis of disease, HLA/T cell recognition.

Published in:: International Journal of Rheumatic Diseases, 2012, v. 15, p. 1, doi. 10.1111/j.1756-185X.2012.01771.x
Publication type:: Article

Topical rosiglitazone treatment improves ulcerative colitis by restoring peroxisome proliferator-activated receptor-gamma activity.

Published in:: Inflammatory Bowel Disease Monitor, 2010, v. 11, n. 2, p. 82
Publication type:: Article

Addition of rosiglitazone to glucose-lowering therapy in people with type 2 diabetes increases adverse effects.

Published in:: Australian Journal of Pharmacy, 2009, v. 90, n. 1073, p. 67
Publication type:: Article

Influence of Rosiglitazone on the Expression of PPARγ, NF-κB, and TNF-α in Rat Model of Ulcerative Colitis.

Published in:

Gastroenterology Research & Practice, 2012, p. 1, doi. 10.1155/2012/845672

By:

Jing-Wei Mao;
Hai-Ying Tang;
Ying-De Wang

Publication type:

Article

Insulin sensitizers improve learning and attenuate tau hyperphosphorylation and neuroinflammation in 3xTg-AD mice.

Published in:

Journal of Neural Transmission, 2015, v. 122, n. 4, p. 593, doi. 10.1007/s00702-014-1294-z

By:

Yu, Yang;
Li, Xiaojing;
Blanchard, Julie;
Li, Yi;
Iqbal, Khalid;
Liu, Fei;
Gong, Cheng-Xin

Publication type:

Article

Effects of the total flavonoid extracts and the monomers of Daphne genkwa on CYP2C8 activity.

Published in:

Xenobiotica, 2022, v. 52, n. 4, p. 353, doi. 10.1080/00498254.2022.2083531

By:

Hou, Qiaoyu;
Liu, Yanzhi;
Xing, Xueting;
Li, Shuo;
Li, Jiaqi;
Qian, Wen;
Yang, Changqing;
Li, Hanhan

Publication type:

Article

Lipids control mucus production in cystic fibrosis.

Published in:

Nature Medicine, 2010, v. 16, n. 3, p. 267, doi. 10.1038/nm0310-267

By:

Gulbins, Erich

Publication type:

Article

Effect of chronic treatment with Rosiglitazone on Leydig cell steroidogenesis in rats: In vivo and ex vivo studies.

Published in:

Reproductive Biology & Endocrinology, 2010, v. 8, p. 13, doi. 10.1186/1477-7827-8-13

By:

Couto, Janaína A.;
Saraiva, Karina L. A.;
Barros, Cleiton D.;
Udrisar, Daniel P.;
Peixoto, Christina A.;
Vieira, Juliany S. B. César;
Lima, Maria C.;
Galdino, Suely L.;
Pitta, Ivan R.;
Wanderley, Maria I.

Publication type:

Article

Co-Administration of Conjugated Linoleic Acid and Rosiglitazone Increases Atherogenic Co-Efficient and Alters Isoprenaline-Induced Vasodilatation in Rats Fed High Fat Diet.

Published in:

Physiological Research, 2018, v. 67, n. 5, p. 729, doi. 10.33549/physiolres.933706

By:

CHAI, B. K.;
LAU, Y. S.;
LOONG, B. J.;
RAIS, M. M.;
TING, K. N.;
DHARMANI, D. M.;
MOHANKUMAR, S. K.

Publication type:

Article

Rosiglitazone Influences the Expression of Leukocyte Adhesion Molecules and CD14 Receptor in Type 2 Diabetes Mellitus Patients.

Published in:

Physiological Research, 2014, v. 63, n. S2, p. S293, doi. 10.33549/physiolres.932791

By:

ŠTULC, T.;
SVOBODOVÁ, H.;
KRUPIČKOVÁ, Z.;
DOLEŽALOVÁ, R.;
MARINOV, I.;
ČEŠKA, R.

Publication type:

Article

Modulation of Baroreflex Function by Rosiglitazone in Prediabetic Hyperglycemic Rats.

Published in:

Physiological Research, 2012, v. 61, n. 5, p. 443, doi. 10.33549/physiolres.932304

By:

HONG, L.-Z.;
CHAN, Y.-C.;
WANG, M.-F.;
WANG, J.-Y.;
HUNG, S.-W.;
TSAI, C.-I.;
TSENG, C.-J.

Publication type:

Article

The Effect of Rosiglitazone on the Expression of Thrombogenic Markers on Leukocytes in Type 2 Diabetes Mellitus.

Published in:

Physiological Research, 2009, v. 58, n. 5, p. 701, doi. 10.33549/physiolres.931573

By:

Svobodová, H.;
Štulc, T.;
Kasalová, Z.;
Doležalová, R.;
Marinov, I.;
Capek, P.;
Ceska, R.

Publication type:

Article

Rosiglitazone Role in the Expression of KLF6 Caco-2 Colon Cancer Cells.

Published in:

International Journal of Morphology, 2017, v. 35, n. 1, p. 259, doi. 10.4067/S0717-95022017000100042

By:

Rojas, Víctor;
Laime, Delia

Publication type:

Article

PPARγ activation but not PPARγ haplodeficiency affects proangiogenic potential of endothelial cells and bone marrow-derived progenitors.

Published in:

Cardiovascular Diabetology, 2014, v. 13, n. 1, p. 1, doi. 10.1186/s12933-014-0150-7

By:

Kotlinowski, Jerzy;
Grochot-Przeczek, Anna;
Taha, Hevidar;
Kozakowska, Magdalena;
Pilecki, Bartosz;
Skrzypek, Klaudia;
Bartelik, Aleksandra;
Derlacz, Rafal;
Horrevoets, Anton J. G.;
Pap, Attila;
Nagy, Laszlo;
Dulak, Jozef;
Jozkowicz, Alicja

Publication type:

Article

Long term liver specific glucokinase gene defect induced diabetic cardiomyopathy by up regulating NADPH oxidase and down regulating insulin receptor and p-AMPK.

Published in:

Cardiovascular Diabetology, 2014, v. 13, n. 1, p. 3, doi. 10.1186/1475-2840-13-24

By:

Hui Li;
Xi Wang;
Yiqing Mao;
Ruobi Hu;
Wei Xu;
Zhen Lei;
Na Zhou;
Ling Jin;
Tingting Guo;
Zhixin Li;
Irwin, David M.;
Gang Niu;
Huanran Tan

Publication type:

Article

Vitamin D supplementation in patients with diabetes mellitus type 2 on different therapeutic regimens: a one-year prospective study.

Published in:

Cardiovascular Diabetology, 2013, v. 12, n. 1, p. 1, doi. 10.1186/1475-2840-12-113

By:

Alkharfy, Khalid M.;
Al-Daghri, Nasser M.;
Sabico, Shaun B.;
Al-Othman, Abdulaziz;
Moharram, Osama;
Alokail, Majed S.;
Al-Saleh, Yousef;
Kumar, Sudhesh;
Chrousos, George P.

Publication type:

Article